BiliaryTractCancer near Sun City Center, FL

Care Philosophy: Dr Dilling's primary clinical focus is the radiotherapeutic treatment of thoracic malignancies.Dr Dilling's research interests focus around the use of Big Data and artificial intelligence to generate novel insights into patient treatment and toxicity. To that end, he has curated a database of thousands of patients who have received radiotherapy to the lung at Moffitt (millions of data points). This data set is among the largest/most complex clinical data sets on radiotherapy patients in the world.

Care Philosophy: Dr Andrew (Andy) Brohl is a medical oncologist and physician-scientist. His clinical interest is in the care of patients with a diagnosis of sarcoma or a cutaneous (skin) malignancy, including melanoma. Dr Brohl's laboratory research focuses on the utilization of genomics and other high-throughput technologies to learn more about rare cancers and for clinically translational applications. Examples of his current projects include genomic analysis of rare cancer subtypes, identification of drug targets from -omics datatypes, application of genomics for personalized cancer therapy, and development of non-invasive molecular profiling technology.

Care Philosophy: Dr Ricardo Gonzalez is a surgical oncologist and Chair of the Sarcoma Department at Moffitt Cancer Center. He also serves as a member of the Cutaneous Program at Moffitt Cancer Center. He is an associate professor at the University Of South Florida College Of Medicine's Department of Oncologic Sciences and Department of Surgery. Dr Gonzalez' research and clinical interests include outcomes analyses and management of patients with soft tissue sarcomas, retroperitoneal sarcomas, desmoid tumors, gastrointestinal stromal tumors (GIST) and head and neck melanoma.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr G Daniel Grass is an Assistant Member and clinical-investigator in the Department of Radiation Oncology. Dr Grass received his MD and PhD in Molecular and Cellular Biology and Pathobiology from the Medical University of South Carolina, Medical Scientist Training Program. He completed a Radiation Oncology Residency at Moffitt Cancer Center/University of South Florida. He is focused on treating patients with genitourinary malignancies (e.g. prostate, bladder, kidney, penile, ureter, testicular) by implementing novel approaches with leading edge radiation technologies.

Care Philosophy: Dr Wuthrick specializes in radiation therapy for skin cancers such as melanoma, Merkel cell carcinoma, squamous cell carcinoma, and basal cell carcinoma. He is also clinically interested in gastrointestinal cancers, including esophagealstomach andliver cancers, and cancers of the pancreas, colon, rectum and anus. Dr Wuthrick is interested in the combination of high dose per fraction radiation therapy and immunotherapy in melanoma and Merkel cell carcinoma. He is involved in numerous early phase clinical trials exploring the role of MAPK pathway inhibitors with radiation therapy.

Care Philosophy: Dr Sweet's clinical interests include myeloid malignancies with a particular focus on acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). She completed her medical education at the Medical College of Virginia - Virginia Commonwealth University. Her Internal Medicine residency was completed at the University of Arizona, and her Hematology and Medical Oncology fellowship training was done at Moffitt Cancer Center/The University of South Florida. She is currently an Associate Member in the Department of Malignant Hematology at Moffitt Cancer Center and has an appointment as an Assistant Professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine.

Care Philosophy: Dr James Liu is a neurosurgeon who specializes in the surgical and radiosurgical treatment of brain and spine tumors. Currently, he is an Assistant Member in the Department of Neuro-Oncology at Moffitt Cancer Center and an Assistant Professor of Oncologic Sciences at the University of South Florida. He received his undergraduate education from the University of Michigan. He received a medical degree from Case Western Reserve University School of Medicine. He obtained his residency training in neurosurgery at the Cleveland Clinic. He also completed a post-doctoral fellowship in Cancer Stem Cell Biology at the Cleveland Clinic, during which he was awarded the Congress of Neurological Surgeons Tumor Fellowship.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.